Equipoise Cycle: Results, Dosage, and Side Effects

Equipoise has been floating around bodybuilding circles for decades, but a surprising amount of the information out there is either outdated or flat-out wrong. The biggest issue is that most guides still tell you to run an aromatase inhibitor alongside EQ, when the compound itself actually lowers estrogen. That advice has led to crashed estrogen, wrecked cycles, and a lot of unnecessary suffering.

This guide covers how an equipoise cycle actually works, what dosages and cycle lengths make sense, the side effects you need to watch for, and why your estrogen management strategy with EQ looks nothing like it does with other injectables.

What Is Equipoise (Boldenone Undecylenate)?

The word “equipoise” literally means balance or equilibrium. In the steroid world, it refers to Boldenone Undecylenate, a compound originally developed under the brand name Equipoise for veterinary use in horses. The name stuck, and so did the compound’s reputation for producing balanced, steady results without the dramatic peaks and crashes of faster-acting injectables.

Boldenone is structurally almost identical to Dianabol (Methandrostenolone). The key difference is that it drops the 17-alpha-alkyl group (which makes Dbol liver-toxic) and adds a long undecylenate ester instead. That ester makes it oil-soluble and gives it a slow, sustained release into the bloodstream. Often referred to as the EQ steroid in gym communities, boldenone has built its following on delivering high-quality lean gains that are less dramatic but more keepable than what you get from compounds like Dbol or Anadrol.

EQ’s Aromatase Inhibitor Properties

One of the most misunderstood aspects of boldenone is its relationship with estrogen. Older guides describe EQ as having “mild estrogenic activity” and recommend running an aromatase inhibitor alongside it. This is inaccurate and can cause serious problems.

Boldenone’s primary metabolite, 1,4,6-androstatriene-3,17-dione (ATD), functions as an aromatase inhibitor. In practical terms, Equipoise does not just aromatize at a lower rate than testosterone; it actively reduces estrogen conversion from other compounds in the stack. Running EQ at a 1:1 ratio with testosterone will suppress estrogen in most users. Adding a pharmaceutical AI like Anastrozole on top of that is a common mistake that frequently results in crashed estrogen, producing symptoms like dry joints, fatigue, mood disturbances, low libido, and erectile dysfunction.

A 2012 study published in Toxicology Letters documented boldenone’s effects on steroidogenesis and confirmed its interaction with aromatase activity. The practical takeaway: if you are running EQ, your estrogen management strategy needs to account for this built-in AI effect. Many experienced users run testosterone at a higher ratio than EQ specifically to maintain adequate estrogen levels.

For a broader overview of how steroids interact and how to structure your first protocol, see our guide to the best steroids for beginners.

How a Testosterone and Equipoise Cycle Works

A test and EQ cycle combines Boldenone Undecylenate with a testosterone base, which is necessary because all exogenous androgens suppress natural testosterone production. Without a testosterone base, you will experience low-T symptoms: fatigue, loss of libido, mood crashes, and muscle loss.

The critical difference between EQ cycles and cycles with other compounds is length. Because the undecylenate ester has a half-life of approximately 14 days, Equipoise takes 6-8 weeks to reach stable serum concentrations. Running an EQ cycle for only 10-12 weeks means you spend half the cycle waiting for the compound to fully saturate. Most experienced users run Equipoise for 16-20 weeks minimum.

Testosterone-to-EQ Ratio

Because of EQ’s estrogen-lowering properties, the testosterone-to-EQ ratio matters more than with most other compounds. If you run Test and EQ at equal doses, your estrogen will likely drop below optimal range. The standard approach:

• Higher Test than EQ (e.g., 500mg Test / 400mg EQ) preserves adequate estrogen levels for joint health, mood, and sexual function
• Equal ratio (e.g., 400mg / 400mg) will work for some users but requires bloodwork to verify estrogen has not dropped too low
• Higher EQ than Test will crash estrogen in most individuals and is not recommended unless you have prior bloodwork confirming you are a heavy aromatizer

Sample Cycle Structures

Lean Bulk Cycle (16-20 Weeks)

This is the most commonly reported EQ cycle structure. The higher test-to-EQ ratio ensures estrogen stays in a functional range. If bloodwork at week 6-8 shows elevated estrogen, a low-dose AI can be introduced cautiously, but do not add one preemptively.

Cutting Cycle (16 Weeks)

Test Prop is used here for its shorter ester, allowing faster clearance at the end of the cycle before PCT. The lower EQ dose relative to testosterone prevents estrogen from bottoming out. Adding Anavar at the end provides additional hardening and strength without estrogenic activity.

Intermediate Bulk (20 Weeks)

This protocol uses higher doses and requires more careful monitoring. The slightly higher test-to-EQ ratio (1.2:1) should keep estrogen manageable, but individual response varies significantly.

For more structured cycle examples across different experience levels, see our best steroid cycles guide.

Equipoise Cycle Results: What to Expect

Users consistently describe the same pattern with Equipoise: gains arrive slower than with compounds like Anadrol or high-dose testosterone, but they are leaner, drier, and more sustainable post-cycle. Because EQ does not produce significant water retention, the muscle gained tends to look defined rather than bloated.

Timeline of Reported Results

Weeks 1-4: Minimal visible changes. Increased appetite is often the first noticeable effect. Some users report improved vascularity beginning around week 3-4. This is the saturation period; the compound has not yet reached peak blood levels.

Weeks 5-8: Strength increases become noticeable. Muscle fullness begins developing. Endurance improvements from increased red blood cell production start becoming apparent during longer training sessions. This is when most users “feel” the EQ working.

Weeks 10-16: Significant lean muscle accumulation. Improved muscle definition and pronounced vascularity. If calories are controlled, noticeable improvements in body composition. Training capacity and recovery between sessions are noticeably improved.

Weeks 16-20: Peak results. The compound has been at stable blood concentrations for over 10 weeks. Users who run the full 20-week cycle report the most substantial gains in this final stretch.

Reported lean muscle gains range from 10-20 lbs over a 16-20 week cycle when combined with appropriate training and nutrition. Results vary based on diet, training, genetics, dosage, and whether additional compounds are stacked.

Equipoise Before and After: Typical Visual Changes

Equipoise before and after comparisons typically show gradual improvements in muscle definition and vascularity rather than dramatic size transformations. Users who document their progress over 16-20 week cycles report the most visible differences in shoulder and arm fullness, increased vein visibility, and a leaner overall appearance. Because EQ does not cause significant water retention, the changes in physique photos tend to look “real” rather than inflated, and most of the visual progress from an equipoise cycle is retained post-cycle.

EQ vs. Deca-Durabolin: How Results Compare

Equipoise is sometimes called a “poor man’s Deca,” but the two compounds produce meaningfully different results (see our full Deca-Durabolin cycle guide for Nandrolone-specific protocols):

Deca produces more dramatic size gains but with more water and more complex side-effect management (progesterone-related gyno, “Deca dick”). Equipoise produces leaner gains with a different side-effect profile centered around hematocrit elevation and anxiety.

Equipoise Effects and Benefits

The primary equipoise benefits center on its unique pharmacological profile: moderate but high-quality anabolic activity paired with a long-acting ester and built-in estrogen management properties.

1. Gradual Lean Muscle Growth

The equipoise steroid stimulates nitrogen retention and protein synthesis in muscle tissue. Unlike faster-acting compounds, the gains accumulate gradually but are reported to be of higher quality, consisting of less water and more contractile muscle tissue. This is partly due to EQ’s low aromatization rate and the long ester providing stable, sustained serum levels without the peaks and troughs of shorter-estered compounds.

2. Increased Red Blood Cell Production

One of boldenone’s most documented pharmacological effects is stimulation of erythropoiesis, the production of red blood cells. A study published in the British Journal of Haematology confirmed that boldenone stimulates erythropoietin production, increasing red blood cell count.

More red blood cells means improved oxygen delivery to muscle tissue. This translates directly to better training endurance, reduced fatigue, and faster aerobic recovery between sets and sessions. This is why EQ shows up in endurance and athletic performance contexts, not just bodybuilding.

The flip side: excessive red blood cell production raises hematocrit, which increases blood viscosity and cardiovascular risk. This is the most important health marker to monitor during an EQ cycle (covered in the side effects section below).

3. Appetite Stimulation

Equipoise is one of the most reliable appetite stimulators among injectable steroids. Most users report a noticeable and sustained increase in hunger starting around weeks 2-4. For bulking, this is a benefit. For cutting, it requires disciplined nutrition. This appetite effect is frequently cited as a reason to choose or avoid EQ depending on the goal of the cycle.

4. Improved Endurance and Work Capacity

The combination of increased red blood cell production, elevated nitrogen retention, and steady serum levels collectively increases an athlete’s training capacity. Users report training at higher intensity for longer durations before fatigue sets in. Strength increases tend to be moderate compared to compounds like Trenbolone or high-dose testosterone, but the endurance benefit is more pronounced.

5. Collagen Synthesis Support

Boldenone has been reported to support collagen synthesis, which may contribute to connective tissue health during heavy training phases. This is less well-documented than its effects on muscle tissue and erythropoiesis, but it is a frequently cited anecdotal benefit among long-term users.

Equipoise Side Effects

1. Elevated Hematocrit and Blood Viscosity

This is the primary health concern with Equipoise and the reason bloodwork is non-negotiable. EQ’s stimulation of red blood cell production raises hematocrit (the percentage of blood volume occupied by red blood cells). Hematocrit above 54% significantly increases the risk of blood clots, stroke, and cardiovascular events.

Management: Regular blood work (CBC panel) every 6-8 weeks during the cycle. If hematocrit exceeds 52-54%, standard interventions include therapeutic phlebotomy (blood donation or removal), hydration optimization, and potentially reducing the EQ dose. Grapefruit and naringin supplementation have been anecdotally reported to help manage hematocrit, though clinical evidence for this application is limited.

2. Anxiety and Mental Health Effects

EQ-related anxiety is one of the most commonly reported subjective side effects and is often underrepresented in guides. Users describe a persistent, low-grade anxiety that is distinct from the aggression associated with compounds like Trenbolone. The mechanism is not fully understood but may relate to EQ’s impact on neurosteroid metabolism and its estrogen-lowering effect, since low estrogen itself causes anxiety in men.

If anxiety becomes disruptive, the first step is checking estrogen levels. Crashed estrogen from EQ’s AI properties is often the root cause. Adjusting the test-to-EQ ratio (increasing test, decreasing EQ) frequently resolves the issue.

3. Cardiovascular Strain

Like all anabolic steroids, boldenone can negatively affect cardiovascular markers. Reported concerns include:

• Elevated LDL cholesterol and suppressed HDL cholesterol
• Raised blood pressure
• Increased blood viscosity from elevated RBC count
• Potential left ventricular hypertrophy with prolonged use

A 2012 study in Toxicology Letters documented adverse effects of boldenone on lipid profiles and liver function in animal models. Cardiovascular health monitoring, including lipid panels and blood pressure tracking, should be standard practice during any EQ cycle.

4. Androgenic Effects

Androgenic side effects, including oily skin, acne, and accelerated hair loss in genetically predisposed individuals, are possible but generally less pronounced than with more androgenic compounds. Equipoise’s low androgenicity (anabolic-to-androgenic ratio of approximately 100:50) makes these effects milder than with testosterone, Trenbolone, or Masteron.

5. Endocrine Suppression

Equipoise suppresses the hypothalamic-pituitary-testicular axis (HPTA), reducing or eliminating natural testosterone production during the cycle. This suppression is why a testosterone base is mandatory and why post-cycle therapy is required. EQ’s extremely long detection time (up to 18 months in some testing protocols) means that metabolites remain in the body far longer than with most other injectable steroids.

6. Potential Organ Stress

Injectable steroids carry lower hepatotoxicity than oral 17-alpha-alkylated compounds, but the liver and kidneys are still involved in processing and eliminating steroid metabolites. Liver and kidney function panels (CMP) should be included in cycle bloodwork. Extended cycles (20+ weeks) and higher doses increase cumulative organ burden.

Equipoise Dosage: Standard Ranges

The right equipoise dosage depends on experience level, goals, and individual response to the compound. The ranges below reflect what is commonly reported in bodybuilding communities.

Equipoise Half-Life and Injection Frequency

The undecylenate ester gives Equipoise a half-life of approximately 14 days, significantly longer than testosterone enanthate (~4.5 days) or testosterone cypionate (~8 days). This long half-life means:

• Injection frequency: Once or twice per week is standard. Some users prefer twice weekly for more stable blood levels, but once weekly is pharmacologically adequate.
• Saturation time: 6-8 weeks to reach stable serum concentrations. Results before this point will be minimal.
• PCT delay: You must wait 4-5 weeks after the last EQ injection before starting PCT to allow the compound to clear sufficiently.

Injection Sites

The most commonly used injection sites are the glutes (gluteal muscles), outer thigh (vastus lateralis), and deltoids. Rotating injection sites between pins reduces localized tissue irritation and scar tissue accumulation, which is especially important on longer cycles.

Post-Cycle Therapy After an Equipoise Cycle

Post-cycle therapy is required after every Equipoise cycle. The purpose is to restart the body’s natural testosterone production, which is suppressed during the cycle. Skipping PCT risks prolonged hypogonadism, mood disturbances, loss of cycle gains, and sexual dysfunction.

PCT Timing for EQ

This is where Equipoise differs from most other compounds. Because of the long undecylenate ester (14-day half-life), standard PCT timing does not apply. Starting PCT 2 weeks after your last injection, which is appropriate for testosterone enanthate or cypionate, will not work for EQ because active boldenone is still clearing the body.

Recommended timing: Begin PCT approximately 4-5 weeks after the last Equipoise injection. Some users bridge this gap by running testosterone propionate (short ester) for the final 2-3 weeks of the cycle, dropping the EQ early, and then starting PCT 2 weeks after the last Test Prop injection. This approach provides hormonal support during the extended clearance period.

Standard PCT Protocol

Some protocols use both Clomid and Nolvadex simultaneously; others use one or the other. HCG (Human Chorionic Gonadotropin) may be used during the cycle or in the bridge period before PCT to maintain testicular function and make recovery faster.

Bloodwork before, during, and after the cycle is strongly recommended to monitor hormonal recovery. A post-PCT blood panel at 4-6 weeks after completing PCT confirms whether natural testosterone production has recovered.

For a deeper understanding of testosterone-based cycling and PCT principles, see our testosterone enanthate cycle guide.